140 related articles for article (PubMed ID: 1569961)
1. The thyrotropin receptor 25 years after its discovery: new insight after its molecular cloning.
Nagayama Y; Rapoport B
Mol Endocrinol; 1992 Feb; 6(2):145-56. PubMed ID: 1569961
[TBL] [Abstract][Full Text] [Related]
2. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
Kosugi S; Ban T; Akamizu T; Kohn LD
Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
[TBL] [Abstract][Full Text] [Related]
3. [Anti-thyrotropin (TSH) receptor antibody binding epitopes of TSH receptor: site-directed mutagenesis approach].
Akamizu T; Kosugi S; Kohn LD; Mori T
Nihon Rinsho; 1994 Apr; 52(4):1024-30. PubMed ID: 7515117
[TBL] [Abstract][Full Text] [Related]
4. Folding-dependent binding of thyrotropin (TSH) and TSH receptor autoantibodies to the murine TSH receptor ectodomain.
Vlase H; Matsuoka N; Graves PN; Magnusson RP; Davies TF
Endocrinology; 1997 Apr; 138(4):1658-66. PubMed ID: 9075728
[TBL] [Abstract][Full Text] [Related]
5. [The TSH receptor gene and the pathogenesis of Graves' disease].
Nagayama Y; Nagataki S
Nihon Naibunpi Gakkai Zasshi; 1992 Jun; 68(6):584-91. PubMed ID: 1353029
[TBL] [Abstract][Full Text] [Related]
6. Role of the carboxyl-terminal half of the extracellular domain of the human thyrotropin receptor in signal transduction.
Nagayama Y; Rapoport B
Endocrinology; 1992 Aug; 131(2):548-52. PubMed ID: 1322272
[TBL] [Abstract][Full Text] [Related]
7. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
[TBL] [Abstract][Full Text] [Related]
8. Binding of antithyrotropin receptor autoantibodies in Graves' disease serum to nascent, in vitro translated thyrotropin receptor: ability to map epitopes recognized by antibodies.
Morgenthaler NG; Tremble J; Huang G; Scherbaum WA; McGregor AM; Banga JP
J Clin Endocrinol Metab; 1996 Feb; 81(2):700-6. PubMed ID: 8636291
[TBL] [Abstract][Full Text] [Related]
9. Soluble ecto-domain mutant of thyrotropin (TSH) receptor incapable of binding TSH neutralizes the action of thyroid-stimulating antibodies from Graves' patients.
Osuga Y; Liang SG; Dallas JS; Wang C; Hsueh AJ
Endocrinology; 1998 Feb; 139(2):671-6. PubMed ID: 9449640
[TBL] [Abstract][Full Text] [Related]
10. Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships.
Szkudlinski MW; Fremont V; Ronin C; Weintraub BD
Physiol Rev; 2002 Apr; 82(2):473-502. PubMed ID: 11917095
[TBL] [Abstract][Full Text] [Related]
11. The thyrotropin (TSH) receptor transmembrane domain mutation (Pro556-Leu) in the hypothyroid hyt/hyt mouse results in plasma membrane targeting but defective TSH binding.
Gu WX; Du GG; Kopp P; Rentoumis A; Albanese C; Kohn LD; Madison LD; Jameson JL
Endocrinology; 1995 Jul; 136(7):3146-53. PubMed ID: 7789342
[TBL] [Abstract][Full Text] [Related]
12. Different bioactivities of human thyrotropin receptors with different signal peptides.
Park JY; Lee J; Cho BY; Chae CB
Mol Cell Endocrinol; 1999 Jan; 147(1-2):133-42. PubMed ID: 10195700
[TBL] [Abstract][Full Text] [Related]
13. Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor.
Kosugi S; Ban T; Kohn LD
Mol Endocrinol; 1993 Jan; 7(1):114-30. PubMed ID: 8095322
[TBL] [Abstract][Full Text] [Related]
14. Cloning of the single strand DNA-binding protein important for maximal expression and thyrotropin (TSH)-induced negative regulation of the TSH receptor.
Ohmori M; Ohta M; Shimura H; Shimurat Y; Suzuki K; Kohn LD
Mol Endocrinol; 1996 Nov; 10(11):1407-24. PubMed ID: 8923467
[TBL] [Abstract][Full Text] [Related]
15. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
Heyma P; Harrison LC
J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
[TBL] [Abstract][Full Text] [Related]
16. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
[TBL] [Abstract][Full Text] [Related]
17. Site-directed mutagenesis of the human thyrotropin receptor: role of asparagine-linked oligosaccharides in the expression of a functional receptor.
Russo D; Chazenbalk GD; Nagayama Y; Wadsworth HL; Rapoport B
Mol Endocrinol; 1991 Jan; 5(1):29-33. PubMed ID: 2017190
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
Hill BL; Erlanger BF
Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
[TBL] [Abstract][Full Text] [Related]
19. Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors.
Nagayama Y; Wadsworth HL; Russo D; Chazenbalk GD; Rapoport B
J Clin Invest; 1991 Jul; 88(1):336-40. PubMed ID: 1711544
[TBL] [Abstract][Full Text] [Related]
20. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
